openPR Logo
Press release

Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous Thromboembolism (VTE) Market

07-30-2021 01:42 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Venous Thromboembolism (VTE) Market

Venous Thromboembolism (VTE) Market

Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.

Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188

Pulmonary embolism occurs in almost one-third of patients suffering from deep vein thrombosis. VTE can occur at any age, however, it is common in adults aged 60 and above. Moreover, people whose blood is thicker than normal, older, overweight, or suffer from some other diseases such as cancer or autoimmune disorders are at a higher risk of VTE.
VTE affects both men and women equally. Around 60% of VTE cases occur during or after hospitalization. VTE is the third most common cardiovascular disease after coronary artery disease and stroke, and the leading cause of death and disability worldwide. It requires immediate medical treatment that primarily focuses on breaking or preventing the formation of blood clots. Treatment includes blood-thinning agents such as thrombolytic therapy, mechanical devices, and anticoagulants. Increasing prevalence of venous thromboembolism worldwide is expected to drive the venous thromboembolism market growth. According to the International Society on Thrombosis and Hemostasis, Inc., around 10 million cases of VTE occur annually.

Moreover, increasing research and development activities and increasing product approvals from regulatory bodies, such as the Food and Drugs Administration (FDA), are expected to propel the growth of the venous thromboembolism market. For instance, in 2019, Pfizer, received FDA approval for FRAGMIN, for the treatment of VTE in pediatric patients, aged 1 month and above. Moreover, Bayer and JNJ announced new results from the phase III study in children with VTE. However, rising consumer interest towards drug-based VTE treatment is expected to hamper the market growth.

In terms of geography, the venous thromboembolism market is divided into six regions, such as North America, Europe, Asia Pacific, South America, Middle East, and Africa. According to the International Society on Thrombosis and Hemostasis, Inc., every year, around 100,000 to 300,000 VTE-related deaths occur in the U.S. However, the number is much higher in Europe, with around 544,000 deaths every year. This preventable health condition is usually overlooked as a major public health problem leading to deaths. Increasing demand for cost-effective treatment and the well-established healthcare infrastructure in North America and the Asia Pacific is also expected to foster the venous thromboembolism market growth.

Key Vendors of Venous Thromboembolism (VTE) Market: Pfizer Inc., Boehringer Ingelheim GmbH, Sanofi S.A., Abbott Laboratories, Dupont Pharm Co, Bristol-Myers Squibb Company, Merck & Co. Inc., Bayer AG, Upsher-Smith Laboratories, Inc., and 3M Health Care.

“Limited Time Offer”
Buy This Research Study Report With Flat US $2000 Off @: https://www.coherentmarketinsights.com/promo/buynow/188

Table of Content

Global Venous Thromboembolism (VTE) Market Research Report
Section 1: Global Venous Thromboembolism (VTE) Industry Overview
Section 2: Global Economic Impact on Venous Thromboembolism (VTE) Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Venous Thromboembolism (VTE) Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Venous Thromboembolism (VTE) Market Forecast

Contact Us

Name: Mr. Shah
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous Thromboembolism (VTE) Market here

News-ID: 2342141 • Views:

More Releases from Coherent Market Insights

Hydropower Generation Market is Estimated to Witness High Growth Owing to Rising Investments in Renewable Energy Projects
Hydropower Generation Market is Estimated to Witness High Growth Owing to Rising …
Market Overview: Hydropower generation utilizes the power of flowing water to generate electricity through turbines. It is one of the most widely used forms of renewable energy sources and provides clean electricity to households and industries. Market Dynamics: Hydropower generation market is expected to witness significant growth over the forecast period owing to rising investments in renewable energy projects worldwide and favorable government policies supporting clean energy. According to the report, the market
Oleochemicals Market is Estimated to Witness High Growth Owing to Rising Demand from Personal Care Sector
Oleochemicals Market is Estimated to Witness High Growth Owing to Rising Demand …
Market Overview: Oleochemicals are derived from animal and vegetable oils and fats through processes such as hydrolysis and fractionation. They are extensively used in applications such as cosmetics, pharmaceuticals, soaps & detergents, food additives, lubricants, and plasticizers. Market Dynamics: The oleochemicals market is expected to witness significant growth over the forecast period owing to rising demand from personal care products. Rapid urbanization coupled with increasing consumer spending on personal care & cosmetic products
Enzymatic Cleaner Market is Estimated to Witness High Growth Owing to Increasing Demand for Environment Friendly Cleaning Agents
Enzymatic Cleaner Market is Estimated to Witness High Growth Owing to Increasing …
Market Overview: Enzymatic cleaners are product used for household cleaning purposes that contain natural enzymes to break down and remove dirt, stains, and odors. These cleaners are gentle alternative to harsh chemical-based cleaners and are suitable for delicate surfaces like ceramic, marble, fabrics. They efficiently remove protein-based stains like food, blood, and grease without damaging treated surfaces and are preferred for bathroom cleaning. Market Dynamics: Stringent regulations on usage of hazardous chemicals in
Lactic Acid Market is Estimated to Witness High Growth Owing to Increasing Demand from Personal Care Industry
Lactic Acid Market is Estimated to Witness High Growth Owing to Increasing Deman …
Market Overview: Lactic acid is an organic acid produced through fermentation of carbohydrates. It finds application in food & beverage, pharmaceutical and personal care products. It is used as a preservative and flavoring agent in food items. Market Dynamics: Lactic acid is gaining traction in personal care & cosmetics industry owing to its anti-aging and moisturizing properties. It is widely used in lotions, creams as it exfoliates dead skin cells and aids in

All 5 Releases


More Releases for VTE

Venous Thromboembolism Treatment Market | VTE Market 2019 – 2025 | PBIGP
The Rising Market For Venous Thromboembolism Treatment Market And Its Newer Therapeutic Drugs In The Market. Venous thromboembolism is a disease caused by the clotting of blood in the blood vessel which leads to restriction of blood flow within the circulatory system. Venous thromboembolism is classified into pulmonary embolism (PE) and deep vein thrombosis (DVT). Deep vein thrombosis is mainly occurred due to the clotting of the blood in the deep
Venous Thromboembolism (VTE) Market – Global Industry Insights, Trends, Outloo …
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism. Request to download and
Venous Thromboembolism (VTE) Market – Global Industry Insights, Trends and Opp …
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism. There are around 100,000
Venous Thromboembolism (VTE) Market - Global Industry Analysis 2024
According to the International Society on Thrombosis and Haemostasis, Inc., venous thromboembolism (VTE) is a leading cause of death and disability worldwide. Approximately 10 million cases of venous thromboembolism occur annually. VTE refers to the formation of blood clots in vein. If the clot is in deep vein (usually leg), it is called as deep vein thrombosis, while a clot in lungs is termed as pulmonary embolism. Get PDF Research Brochure
EpiCast Report - Global VTE Market Analysis, Trends And Forecast to 2025
"The Report EpiCast Report: Venous Thromboembolism - Epidemiology Forecast to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Venous thromboembolism (VTE), comprised of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded flow of blood, which can have serious consequences in the affected individual. VTE can occur at any
Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020 | Latest R …
Researchmoz added Most up-to-date research on "Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF)-2020" to its huge collection of research reports. “Anticoagulants-Market Insights & Drugs Sales Forecast (VTE & AF) -2020” provides an overview of the Anticoagulants and Atrial Fibrillation and Venous Thromboembolism overview. The Report majorly emphasize on the global Anticoagulants market size and market size of the Anticoagulants by 7Major Markets (United States, EU5 (France, Germany, Italy, Spain,